Single-photon emission computed tomography with 99mTc-exametazime in unmediated schizophrenic patients

Biological Psychiatry

Volumn 33, Issue 7, 1993, Pages 487-495

  Ebmeier, K P ^a   Blackwood, D H R ^a   Murray, C ^a   Souza, V ^a   Walker, M ^a   Dougall, N ^a   Moffoot, A P R ^a   O'Carroll, R E ^a   Goodwin, G M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

cerebral blood flow; schizophrenia; Single photon emission tomography

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NEUROLEPTIC AGENT; TECHNETIUM 99M;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHOTON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SCHIZOPHRENIA;

ADULT; AROUSAL; CEREBRAL CORTEX; DOMINANCE, CEREBRAL; FEMALE; FRONTAL LOBE; HUMAN; MALE; MIDDLE AGE; ORGANOTECHNETIUM COMPOUNDS; OXIMES; PSYCHIATRIC STATUS RATING SCALES; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, NON-U.S. GOV'T; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0027212352     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(93)90002-U     Document Type: Article

References (52)

1. 133Xe
2. Clinical heterogeneity of schizophrenia: Perspectives from neuroimaging
3. Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim
4. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia
5. Importance of pharmacologic control in PET Studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
6. Patterns of metabolic activity in the treatment of schizophrenia
7. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia
8. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients
9. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia
10. Schizophrenia as an anomaly of development of cerebral asymmetry—a study and a proposal concerning the geneticbasis of the disease
11. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients
12. Left globus pallidus abnormality in never-medicated patients with schizophrenia
13. The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker exametazime and single photon emission computed tomography (SPECT): Reproducibility and rater reliability
14. Regional brain glucose metabolism in chronic schizophrenia. A positron emision transaxial tomographic study
15. A PET study of word finding
16. 2 PET
17. Reversibility of hemodynamic hypofrontality in schizophrenia
18. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey
19. Brain function in psychiatric disorders: I. Regional cerebral blood flow in medicated schizophrenics
20. Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics
21. Regional brain function in schizophrenia
22. Single-photon emission computerised tomography (SPECT) in schizophrenia
23. 18F] Fluoromethane PET in cerebrovascular disease
24. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia
25. 2 inhalation steady state method measured by positron emission tomography
26. Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder
27. A controlled study of Tc-99m-HMPAO single-photon emission imaging in chronic schizophrenia
28. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy
29. Schizophrenic syndromes, cognitive performance and neurological dysfunction
30. Syndromes of chronic schizophrenia
31. Schizophrenic syndromes and frontal lobe performance
32. Patterns of cerebral blood flow in schizophrenia
33. Chronicity and a low anterior posterior gradient of cerebral blood-flow in schizophrenia
34. The brief psychiatric rating scale
35. The comparison of brain distribution of HMPAO and microspheres in humans
36. Altered modulation of prefrontal and subcortical brain activity in newly diagnosed schizophrenia and schizophreniform disorder
37. Sylvian fissure size in schizophrenia measured with the magnetic resonance imaging rating protocol of the consortium to establish a registry for Alzheimer's disease
38. Abnormalities of the left temporal lobe and thought disorder in schizophrenia—a quantitative magnetic resonance imaging study
39. The pattern of cerebral activity underlying verbal fluency shown by split-dose single photon emission tomography (SPET or SPECT) in normal volunteers
40. 15-O positron emission tomographic scanning in predominantly nevertrated acute schizophrenic patients
41. Temporal-lobe pathology in schizophrenia—a quantitative magnetic-resonance imaging study
42. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
43. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration
44. Absence of frontal lobe activation in schizophrenia
45. Regional cerebral blood flow in schizophrenia: Repeated studies during a psychotic episode
46. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia
47. PET studies of glucose metabolism in patients with schizophrenia
48. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates
49. Persistence of cerebal metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography
50. SPECT with Tc-HMPAO compared with regional cerebral blood flow measured by PET: effects of linearisation